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BACKGROUND / OBJECTIVE
Rationale
The global prevalence of Gestational Diabetes Mellitus (GDM) 
is estimated to be between 7.5 and 27% 1.  
The information available in Mexico is not sufficient to measure 
the national prevalence of GDM, however it is estimated that it 
varies between 10 and 12% 2,3. 
Screening and diagnostic strategies have been the subject of 
international debate. At this time the oral glucose tolerance test 
(OGTT) is considered the Gold Standard for the diagnosis of 
GDM.
The American Diabetes Association (ADA) recommends three 
venous plasma glucose samples (fasting, 1 h and 2h after the 
intake of 75g of glucose)4. This criteria has been recommended 
for the diagnosis of DMG in Mexico 2,5 .
However,  it is difficult to perform the GDM screening in 
many low-resource settings due to limited access to 
standardized laboratories.
Objective
To compare the efficacy of two point of care (POC) 
models for GDM detection against the plasmatic 2hr 
OGTT-75gr in primary health care clinics in Mexico.
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METHODS AND MATERIALS
We evaluated 328 pregnant women without a previous 
diagnosis of diabetes from a prospective cohort study 'Cuido
mi embarazo'. 
All participants were tested with the gold standard plasmatic 
2hr OGTT-75g for the diagnosis of GDM between the 24th 
and 28th weeks of pregnancy. 
The diagnosis was made based on the criteria of the ADA 
2020, which is the same diagnostic criteria recommended by 
Mexican guidelines.
Simultaneously, we measured with a glucometer (Accu-
Chek Instant®) the glucose concentration either by venous 
whole blood (156 measures) or by capillary whole blood 
(172 measures). 
We evaluated the diagnostic accuracy by calculating 
the sensitivity, specificity, and area under the Curve 
(AUD) of ROC curve of each of the glucometer models 
compared to the 2hr OGTT-75g (Gold Standard).
328 pregnant women without 
previous diagnosis of diabetes
Gold Standard
2hr OGTT-75g
(N=328) 
Model 2
Comparison with glucometer 
measures with capillary 
whole blood.
(N=172)
Model 1 
Comparison with 
glucometer measures with 
venous whole blood.
(N=156)
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OGTT
Measurement
Pearson
correlation 
coefficient
P 
value
AUC of 
ROC curve
(95% CI)
Sensitivity Specificity
Fasting value 0.62
< 0.05
0.81
(0.77-0.85)
100% 63.5%
Value 1 hr. 0.94 0.97
(0.95-0.99)
100% 95.2%
Value 2 hr. 0.93 0.98
(0.97-0.99)
100% 97.3%
AUC of ROC curve
(95% CI)
Sensitivity Specificity
Analysis of model 1
0.81
(0.77-0.85)
100% 62.8%
Model 1 (Venous blood analyzed by glucometer)
Table 2. Pearson correlation coefficient, AUC of ROC curve, sensitivity and 
specificity by each glucose measurements with respect to the Gold Standard
Table 1. AUC of ROC curve, sensitivity and specificity of Model 1 with 
respect to the Gold Standard
RESULTS
Figure 1. AUC of ROC curve of Model 1 and each glucose 
measurements with respect to the Gold Standard 
ROC area of Model 1
ROC area of 1st measurement
ROC area of 2nd measurement
ROC area of 3th measurement 4
OGTT
Measurement
Pearson
correlation 
coefficient
P 
value
AUC of 
ROC curve
(95% CI)
Sensitivity Specificity
Fasting value 0.42
< 0.05
0.77
(0.65-0.89)
76.9% 77.9%
Value 1 hr. 0.56 0.76
(0.52-1.00)
60.0% 93.4%
Value 2 hr. 0.53 0.72
(0.23-1.00)
50.0% 95.8%
AUC of ROC curve
(95% CI)
Sensitivity Specificity
Analysis of model 2
0.76
(0.64-0.87)
78.5% 74.1%
ROC area of Model 2
ROC area of 1st measurement
ROC area of 2nd measurement
ROC area of 3th measurement
Model 2 (Capillary blood analyzed by glucometer)
Table 4. Pearson correlation coefficient, AUC of ROC curve, sensitivity and 
specificity by each glucose measurements with respect to the Gold Standard
Table 3. AUC of ROC curve, sensitivity and specificity of Model 2 with 
respect to the Gold Standard
RESULTS
Figure 2. AUC of ROC curve of Model 2 and each glucose 
measurements with respect to the Gold Standard 
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CONCLUSION AND DISCUSSION
This analysis conducted within the Cohort 'Cuido mi Embarazo' in Mexico aims to analyze alternative strategies for GDM 
screening.
The models we studied are based on the use of a glucometer. The first model focused on performing the OGTT with venous 
whole blood without the need to have a laboratory installed. The second model was considered for those situations where it 
is only possible to have capillary glucose measurements.
Based on our preliminary results, the sensitivity and specificity of both models suggest an opportunity to use alternative 
methods to the Gold Standard where this test cannot be performed. 
In particular, Model 1 (with an AUC of ROC curve of 0.81; 95% CI: 0.77 - 0.85) shows to be a good alternative screening 
strategy by using the same reference values for the diagnosis of GDM than the Gold Standard.
However, we must consider that the use of capillary blood is operationally easier to use in low-resource settings. It requires 
less training, is minimally invasive, is portable, is better accepted by the patient and is cost-effective6. Some studies suggest 
the consideration of capillary blood glucose as a screening alternative for GDM with adequate sensitivity and specificity 7–9
This analysis suggests that Model 2 (with an AUC of ROC curve of 0.76; 95% CI: 0.64 - 0.87)  has good specificity to be 
considered as a screening strategy for GDM by using the same reference values than the Gold Standard.  
It is necessary to carry out additional sensitivity and specificity studies considering different glucose reference 
values to increase their respective diagnostic capacity. 
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